With an oversubscribed $30 million collection B in hand, Carlsmed Inc. is in a great posture to take the subsequent steps in its plan to make its customized spinal implants central to ending frequent revisions in backbone surgical procedure. The corporate’s Aprevo gadgets, that are 3D printed for every affected person, acquired FDA breakthrough gadget designation and 510(okay) clearance in late 2020.
